Epidemiology of SARS-CoV-2 during the first three waves in Scotland: a national record linkage study

Abstract

BackgroundThe early COVID-19 pandemic in Scotland—defined as the era before widespread access to vaccination and monoclonal antibody treatment—can be characterised into three distinct waves: March–July 2020, July 2020–April 2021 and May–August 2021. Each wave was met with various societal restrictions in an effort to reduce disease transmission and associated morbidity and mortality. Understanding the epidemiology of infections during these waves can provide valuable insights into future pandemic planning.MethodsScottish RT-PCR testing data reported up until 8 August 2021, the day prior to most restrictions being lifted in Scotland, were included. Demographic characteristics including age, sex and social deprivation associated with transmission, morbidity and mortality were compared across waves. A case–control analysis for each wave was then modelled to further compare risk factors associated with death over time.ResultsOf the 349 904 reported cases, there were 18 099, 197 251 and 134 554 in waves 1, 2 and 3, respectively. Hospitalisations, intensive care unit admissions and deaths appeared highest in wave 2, though risk factors associated with COVID-19 death remained similar across the waves. Higher deprivation and certain comorbidities were associated with higher deaths in all waves.ConclusionsDespite the higher number of cases reported in waves 2 and 3, case fatality rates were lower: likely a combination of improved detection of infections in younger age groups, introduction of social measures and vaccination. Higher social deprivation and comorbidities resulted in higher deaths for all waves.

Risk of COVID‐19 death for people with a pre‐existing cancer diagnosis prior to COVID‐19‐vaccination: A systematic review and meta‐analysis

“…The 39 studies included data from 12 countries (Table 1). 16‐54 After exclusion of studies due to overlapping data, 33 studies were included in the quantitative analyses, of which 28 were included in the main analyses (including analyses restricted to cancer types or metastatic/non‐metastatic cancers), with data from >27 565 252 individuals including >229 642 people with active or recent cancer. Of these 28 studies, 4 focused on the general population, 9 on all people with COVID‐19 and 16 on hospital inpatients with COVID‐19 (one study provided results for both the general population and all people with COVID‐19).…”

Comparative assessment of SARS CoV2-associated mortalities in 3 COVID waves and related risk factors: The South Kashmir’s experience

“…In accordance, Leslie k et al . [ 9 ] in the epidemiological survey of Scotland has substantiated a surge of SARS-CoV-2–associated hospitalization, admissions in ICUs, and mortalities in the second wave. Contrastingly, a multicenter retrospective analysis of adults aged ≥65 years marked an average mortality of 23.9%, where the first and the second waves had analogous outcomes compared to the third wave which revealed a moderate decline.…”

Community antibiotic prescribing in patients with COVID-19 across three pandemic waves: a population-based study in Scotland, UK

“…COVID-19 episodes were categorised into pandemic waves as previously defined for Scotland, 19 with the end dates of each wave extended to prevent gaps in the study period. Wave 1 started on 28 February 2020, wave 2 on 1 August 2020 and wave 3 on 1 May 2021.…”